Maxim Group Has Lowered Expectations for Tenon Medical (NASDAQ:TNON) Stock Price

Tenon Medical (NASDAQ:TNON) had its target price reduced by Maxim Group from $22.00 to $8.00 in a report released on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $3.00 price objective on shares of Tenon Medical in a research report on Wednesday, August 14th.

Tenon Medical Stock Down 8.1 %

Shares of Tenon Medical stock opened at $2.49 on Friday. The firm’s 50 day moving average price is $4.03 and its 200-day moving average price is $1.89. Tenon Medical has a 52-week low of $2.46 and a 52-week high of $20.00. The company has a market cap of $1.27 million, a P/E ratio of -0.09 and a beta of 2.15.

Tenon Medical Company Profile

Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.